Literature DB >> 3607877

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

M Koenig, E P Hoffman, C J Bertelson, A P Monaco, C Feener, L M Kunkel.   

Abstract

The 14 kb human Duchenne muscular dystrophy (DMD) cDNA corresponding to a complete representation of the fetal skeletal muscle transcript has been cloned. The DMD transcript is formed by at least 60 exons which have been mapped relative to various reference points within Xp21. The first half of the DMD transcript is formed by a minimum of 33 exons spanning nearly 1000 kb, and the remaining portion has at least 27 exons that may spread over a similar distance. The DNA isolated from 104 DMD boys was tested with the cDNA for detection of deletions and 53 patients exhibit deletion mutations. The majority of deletions are concentrated in a single genomic segment corresponding to only 2 kb of the transcript.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607877     DOI: 10.1016/0092-8674(87)90504-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  643 in total

Review 1.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

2.  Identification and quantification of somatic mosaicism for a point mutation in a Duchenne muscular dystrophy family.

Authors:  T A Smith; S C Yau; M Bobrow; S J Abbs
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

3.  Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

Authors:  G S Lynch; R T Hinkle; J S Chamberlain; S V Brooks; J A Faulkner
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

4.  The molecular basis of X-linked spondyloepiphyseal dysplasia tarda.

Authors:  A K Gedeon; G E Tiller; M Le Merrer; S Heuertz; L Tranebjaerg; D Chitayat; S Robertson; I A Glass; R Savarirayan; W G Cole; D L Rimoin; B G Kousseff; H Ohashi; B Zabel; A Munnich; J Gecz; J C Mulley
Journal:  Am J Hum Genet       Date:  2001-05-08       Impact factor: 11.025

5.  Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.

Authors:  Paul S Sharp; Hema Bye-a-Jee; Dominic J Wells
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

6.  "Quadriceps myopathy": a clinical variant form of Becker muscular dystrophy.

Authors:  Y Wada; Y Itoh; T Furukawa; H Tsukagoshi; K Arahata
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

7.  Characterization of patients with glycerol kinase deficiency utilizing cDNA probes for the Duchenne muscular dystrophy locus.

Authors:  J A Towbin; D R Wu; J Chamberlain; P D Larsen; W K Seltzer; E R McCabe
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

8.  Truncated dystrophins can influence neuromuscular synapse structure.

Authors:  Glen B Banks; Jeffrey S Chamberlain; Stanley C Froehner
Journal:  Mol Cell Neurosci       Date:  2009-01-08       Impact factor: 4.314

9.  Mutation analysis in a population-based cohort of boys with Duchenne or Becker muscular dystrophy.

Authors:  Christopher Cunniff; Jennifer Andrews; F John Meaney; Katherine D Mathews; Dennis Matthews; Emma Ciafaloni; Timothy M Miller; John B Bodensteiner; Lisa A Miller; Katherine A James; Charlotte M Druschel; Paul A Romitti; Shree Pandya
Journal:  J Child Neurol       Date:  2008-12-12       Impact factor: 1.987

10.  Investigation of Poor Academic Achievement in Children with Duchenne Muscular Dystrophy.

Authors:  V J Hinton; D C De Vivo; R Fee; E Goldstein; Y Stern
Journal:  Learn Disabil Res Pract       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.